Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Genes, Chromosomes & Cancer|August 5, 2000
Decreased expression of the INK4 family of cyclin-dependent kinase inhibitors in Wilms tumorM Y Arcellana-Panlilio, R M Egeler, E Ujack, et al.
Pediatric Research|August 6, 2000
Further evidence for genetic heterogeneity in familial hemophagocytic lymphohistiocytosis (FHLH)G E Graham, L M Graham, P J Bridge, et al.
Medical and Pediatric Oncology|January 1, 1991
Childhood malignant lymphoma of boneM J Coppes, C Patte, D Couanet, et al.
The American Journal of Pediatric Hematology/Oncology|August 1, 1992
Oxygen therapy in sickle cell diseaseA Zipursky, I C Robieux, E J Brown, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|December 1, 1992
Coordinate expression of Wilms' tumor genes correlates with Wilms' tumor phenotypesH Yeger, C Cullinane, A Flenniken, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1989
Bilateral Wilms' tumor: long-term survival and some epidemiological featuresM J Coppes, J de Kraker, P J van Dijken, et al.
Medical and Pediatric Oncology|October 23, 1997
Fractionated cylophosphamide and back to back high dose methotrexate and cytosine arabinoside improves outcome in patients with stage III high grade small non-cleaved cell lymphomas (SNCCL): a randomized trial of the Pediatric Oncology GroupM L Brecher, M R Schwenn, M J Coppes, et al.
Pediatric Hematology and Oncology|October 1, 1992
Analgesia in children with sickle cell crisis: comparison of intermittent opioids vs. continuous intravenous infusion of morphine and placebo-controlled study of oxygen inhalationI C Robieux, J D Kellner, M J Coppes, et al.
Journal of Pediatric Hematology/Oncology|August 13, 1999
Safety, tolerability, antiemetic efficacy, and pharmacokinetics of oral dolasetron mesylate in pediatric cancer patients receiving moderately to highly emetogenic chemotherapyM J Coppes, R Yanofsky, S Pritchard, et al.
Genes, Chromosomes & Cancer|November 1, 1992
Loss of heterozygosity mapping in Wilms tumor indicates the involvement of three distinct regions and a limited role for nondisjunction or mitotic recombinationM J Coppes, L Bonetta, A Huang, et al.
Pageof 6